文献速递前列腺癌

11碳-乙酸PET/CT检测前列腺癌淋巴结转移的组织学验证

Histological Validation of 11Carbon-Acetate Positron Emission Tomography/Computerized Tomography in Detecting Lymph Node Metastases in Prostate Cancer.
PubMed 文献 · J Urol · 2019-01-01

本研究对25例11C-乙酸PET/CT阳性的前列腺癌患者行扩大淋巴结清扫,按8个解剖区域匹配影像与组织学。共切除2149枚淋巴结,528枚(22%)有转移。11C-乙酸PET/CT的灵敏度67%、特异度84%、阳性预测值74%、阴性预测值79%,检出率随转移灶长径增大而提高。

要点

  • 11C-乙酸PET/CT检测前列腺癌淋巴结转移的灵敏度67%、特异度84%。
  • 转移灶长径≤5mm至≥21mm的检出率从45%升至100%。
  • SUV每增加1单位,淋巴结长径增加1.9mm、短径增加1.2mm(p<0.001)。

核心结论

  • 11C-乙酸PET/CT可识别前列腺癌转移性淋巴结,但低估了淋巴结受累的真实头侧范围,盆腔表现优于腹膜后。

研究设计与样本

  • 对25例11C-乙酸PET/CT显示盆腔/腹膜后淋巴结阳性的前列腺癌患者行扩大机器人淋巴结清扫,按8个预定解剖区域标准化模板切除,进行区域匹配的影像与组织学分析。

主要发现

  • 25例共切除2149枚淋巴结(每例平均86枚,范围27-136),528枚(22%)有转移(每例平均21枚阳性,范围0-109)。
  • 174个解剖区域有匹配的影像与组织学数据,11C-乙酸PET/CT准确识别48个阳性区域、准确排除88个无转移区域。
  • 11C-乙酸PET/CT灵敏度67%、特异度84%、阳性预测值74%、阴性预测值79%。
  • 组织学转移灶长径≤5、6-10、11-15、16-20、≥21mm对应的11C-乙酸检出率分别为45%、62%、81%、89%、100%。
  • SUV每增加1单位,淋巴结长径增加1.9mm(p<0.001)、短径增加1.2mm(p<0.001);阳性11C-乙酸PET/CT与淋巴结长径12mm/短径6mm、转移灶长径11mm/短径6mm及结外侵犯相关(阳性88% vs 假阴性58%,p=0.005)。

临床怎么用

  • 11C-乙酸PET/CT可用于前列腺癌淋巴结转移的无创评估,但需注意其对腹膜后及小转移灶的低估。

局限性

  • 样本量较小(25例),仅纳入11C-乙酸PET/CT阳性患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Conventional imaging cannot definitively detect nodal metastases of prostate cancer. We histologically validated C-acetate positron emission tomography/computerized tomography to identify nodal metastases, examining prostate cancer factors that influence detection rates. MATERIALS AND METHODS: Patients with C-acetate avid positron emission tomography/computerized tomography imaged pelvic/retroperitoneal lymph nodes underwent high extended robotic lymphadenectomy. A standardized mapping template comprising 8 predetermined anatomical regions was dissected during lymphadenectomy, allowing for matched, region based analysis and comparison of imaging and histological data. RESULTS: In 25 patients a total of 2,149 lymph nodes were excised (mean 86 per patient, range 27 to 136) and 528 (22%) harbored metastases (mean 21 positive nodes per patient, range 0 to 109). A total of 174 anatomical regions had matching imaging histological data. C-acetate positron emission tomography/computerized tomography accurately identified 48 node-positive regions and accurately ruled out 88 regions as metastasis-free. C-acetate sensitivity, specificity, and positive and negative predictive values were 67%, 84%, 74% and 79%, respectively. An increasing, histologically measured metastatic lesion size in long axis diameter of 5 or less, 6 to 10, 11 to 15, 16 to 20 and 21 mm or greater correlated with improved C-acetate detection rates of 45%, 62%, 81%, 89% and 100%, respectively. Each standard uptake value unit increase correlated with a 1.9 mm increase in nodal long axis diameter (p <0.001) and a 1.2 mm increase in short axis diameter (p <0.001). Positive C-acetate positron emission tomography/computerized tomography findings correlated with histological lymph node size (long axis diameter 12 mm and short axis diameter 6 mm), metastatic lesion size (long axis diameter 11 mm and short axis diameter 6 mm) and extranodal extension (positive 88% vs false-negative 58%, p = 0.005). CONCLUSIONS: C-acetate positron emission tomography/computerized tomography can identify prostate cancer metastatic nodal disease. However, it underestimates the true cephalad extent of nodal involvement, performing better in the pelvis than in the retroperitoneum. Standard uptake value, histological nodal size, intranodal metastasis size and extranodal extension correlate with cancer bearing nodes.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Rajarubendra N, Almeida F, Manojlovic Z, et al. Histological Validation of 11Carbon-Acetate Positron Emission Tomography/Computerized Tomography in Detecting Lymph Node Metastases in Prostate Cancer. J Urol. 2019. PMID: 30218760. doi:10.1016/j.juro.2018.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。